Houston (1)

Metastatic Kidney Medullary Carcinoma (1)

Metastatic Renal Cell Carcinoma (1)

SMARCB1 Negative (1)

Stage III Renal Cell Cancer AJCC v8 (1)

Stage IV Renal Cell Cancer AJCC v8 (1)

Recruiting (1)

phase 2 (1)

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

doxorubicin (1)

doxorubicin hydrochloride (1)

gemcitabine (1)

gemcitabine hydrochloride (1)

ixazomib (1)

ixazomib citrate (1)

drug (1)

Other (1)

Interventional (1)

smarcb1 negative

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jan 20, 2023